Instrumentation

WHITE PAPERS AND CASE STUDIES

• Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies

  To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.

• Rapid Assessment Of Fab-VHH Expression

  Find out how a 10-day expression screening program rapidly identified optimal gene orientation for a bi-specific antibody fragment fusion, achieving up to 570 µg/mL soluble, active product.

• Addressing A Global Health Priority In Australia And New Zealand

  For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.

• Accelerate European Market Access With MAA Submission

  Discover how ensuring preparedness for Marketing Authorization Application (MAA) approval can streamline your application process and subsequent follow-up.

• Development To Large-Scale cGMP Production

  For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.

• Acoustic Sewer Inspection Saves Oakland, Maine, Time And Money

  Discover how the SL-Rat program realized over $51,000 in crew labor and financial savings, while reducing the risk of sanitary sewer maintenance issues, for the town of Oakland, Maine.

• Bringing Clinical Testing To New Heights In New Jersey

  Explore how clinical testing was transformed with a pioneering BSL-2 mobile laboratory on a Sprinter Van platform to enhance safety and portability for advanced biosafety requirements.

• How To Unlock The Secret To Repeatable, Scalable Low Turnover

  Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

• Diagnosing COVID-19 And Other Infectious Diseases In Remote Locations

  Learn about the cutting-edge mobile BSL-3 laboratory that was custom-built in response to a need for a flexible diagnostic testing solution in the United Arab Emirates due to a surge in COVID-19 cases.

• Time-To-Manufacture Reduced By 30% Through Rapid Transfer Strategy

  Critical formulation deficiencies were solved through rapid batch manufacturing and process adjustments. This enabled a 30% reduction in time-to-manufacture and prevented delays to the start date.

• A Streamlined Biopharmaceutical Isolator Solution

  This custom-designed, eight-foot isolator helped a client meet their decontamination needs, maintaining ISO-5 sterile conditions while decreasing turn-around time for filling small batches.

• Asset Reinduction To Maximo EAM, Enabled By Reality Capture

  Find out how reality capture was used to create a digital twin 750,000-square-foot Pfizer campus to support asset reinduction to Maximo EAM, saving Pfizer 3,000 hours per year.